Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Investigation of the Sleep Architecture and Consequent Cognitive Changes in Olanzapine-Treated Depressed Patients

NCT00520507 is registered in ClinicalTrials.gov with Queen's University as lead sponsor.

NCT NCT00520507
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00520507 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Investigation of the Sleep Architecture and Consequent Cognitive Changes in Olanzapine-Treated Depressed Patients
Lead sponsor
Queen's University
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2007
Completion date
May 31, 2009
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, depression, depressive disorder